跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
KEYTRUDA
Authorized
STANDARD
KEYTRUDA
Merck Canada Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
f1d88b66c85ee090
Company
Merck Canada Inc
Type
Standard
Approval Details
Approval Id
f1d88b66c85ee090
Drug Approval Canada Name
KEYTRUDA
Product Name
KEYTRUDA
Status
Marketed
Status Date
2017-07-13
Original Market Date
2017-07-13
Din
02456869
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Schedule D , Prescription
Ahfs
10:00.00
Atc Original
L01FF02 PEMBROLIZUMAB
Atc Name
l 01 ff 02
Aig Number
0156910003
Company Name
Merck Canada Inc
Company Address
16750 Route Transcanadienne, Kirkland, Quebec, Canada, H9H 4M7
Active Ingredients
PEMBROLIZUMAB
25 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
f1d88b66c85ee090
Type
Standard
Back to Health Canada Approvals
KEYTRUDA - Health Canada Drug Approval Details